Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples

References

• Hyman SE . Neurotransmitters. Curr. Biol.15(5), R154–R158 (2005).
   PubMed Web of Science ®Google Scholar
• Haines DE , NobackCR, MatthewsPBCet al. Human nervous system – anatomy. Encyclopedia Britannica (2006).
   Google Scholar
• Aun AaK , MostafaAA, AboulFotouh AMet al. Role of magnetic resonance spectroscopy (MRS) in nonlesional temporal lobe epilepsy. Egypt. J.Radiol. Nucl. Med.47(1), 217–231 (2016).
   Google Scholar
• Okoye EC , ObiGC, AkosileCOet al. Community integration of people living with epilepsy in a Nigerian population. Epilepsy Res.128, 21–26 (2016).
   PubMed Web of Science ®Google Scholar
• Sillanpaa M , LastunenS, HeleniusH, SchmidtD. Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23-year registry study. Epilepsia52(10), 1857–1867 (2011).
   PubMed Web of Science ®Google Scholar
• Bruun E , KälviäinenR, KeränenT. Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy. Epilepsy Res.127, 60–65 (2016).
   PubMed Web of Science ®Google Scholar
• Hirfanoglu T , SerdarogluA, KurtGet al. Outcomes of resective surgery in children and adolescents with focal lesional epilepsy: the experience of a tertiary epilepsy center. Epilepsy Behav.63, 67–72 (2016).
   PubMed Web of Science ®Google Scholar
• Otsuki T , HondaR, TakahashiAet al. Surgical management of cortical dysplasia in infancy and early childhood. Brain Dev.35(8), 802–809 (2013).
   PubMed Web of Science ®Google Scholar
• Jayakar A , BoltonJ. Pediatric epilepsy surgery. Curr. Neurol. Neurosci. Rep.15(6), 31 (2015).
   PubMed Web of Science ®Google Scholar
• French JA , PeruccaE. Time to start calling things by their own names? The case for antiseizure medicines. Epilepsy Curr.20(2), 69–72 (2020).
   PubMed Web of Science ®Google Scholar
• Shawahna R , AtrashA, JebrilAet al. Pharmacists’ knowledge of issues in pharmacotherapy of epilepsy using antiepileptic drugs: a cross-sectional study in Palestinian pharmacy practice. Epilepsy Behav.67, 39–44 (2017).
   PubMed Web of Science ®Google Scholar
• Saxena VS , NadkarniVV. Nonpharmacological treatment of epilepsy. Ann. Indian Acad. Neurol.14(3), 148–152 (2011).
   PubMed Web of Science ®Google Scholar
• Lee JW , DworetzkyB. Rational polytherapy with antiepileptic drugs. Pharmaceuticals (Basel)3(8), 2362–2379 (2010).
   PubMedGoogle Scholar
• Andrew T , MilinisK, BakerG, WieshmannU. Self reported adverse effects of mono and polytherapy for epilepsy. Seizure21(8), 610–613 (2012).
   PubMed Web of Science ®Google Scholar
• De Zélicourt M , DeToffol B, VespignaniHet al. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study). Seizure23(5), 349–356 (2014).
   PubMed Web of Science ®Google Scholar
• Santulli L , CoppolaA, BalestriniS, StrianoS. The challenges of treating epilepsy with 25 antiepileptic drugs. Pharmacol. Res.107, 211–219 (2016).
   PubMed Web of Science ®Google Scholar
• Golyala A , KwanP. Drug development for refractory epilepsy: the past 25 years and beyond. Seizure44, 147–156 (2017).
   PubMed Web of Science ®Google Scholar
• Brigo F , AussererH, TezzonF, NardoneR. When one plus one makes three: the quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacy. Epilepsy Behav.27(3), 439–442 (2013).
   PubMed Web of Science ®Google Scholar
• Perucca E , BialerM. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Clin. Pharmacokinet.31(1), 29–46 (1996).
   PubMed Web of Science ®Google Scholar
• Coupez R , StraetemansR, SehgalGet al. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets. J. Clin. Pharmacol.43(12), 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Patsalos PN . Clinical pharmacokinetics of levetiracetam. Clin. Pharmacokinet.43(11), 707–724 (2004).
   PubMed Web of Science ®Google Scholar
• Yuan Y , PeizhiZ, MalingGet al. The efficacy of levetiracetam for patients with supratentorial brain tumors. J. Clin. Neurosci.22(8), 1227–1231 (2015).
   PubMed Web of Science ®Google Scholar
• Perucca E , DulacO, ShorvonS, TomsonT. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs15(8), 609–621 (2001).
   PubMed Web of Science ®Google Scholar
• Pucci V , BugamelliF, MandrioliRet al. High-performance liquid chromatographic determination of levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed. Chromatogr.18(1), 37–44 (2004).
   PubMed Web of Science ®Google Scholar
• Kang JS , LeeMH. Overview of therapeutic drug monitoring. Korean J. Intern. Med.24(1), 1–10 (2009).
   PubMedGoogle Scholar
• Sourbron J , ChanH, Wammes-VanDer Heijden EAet al. Review on the relevance of therapeutic drug monitoring of levetiracetam. Seizure62, 131–135 (2018).
   PubMed Web of Science ®Google Scholar
• Jarvie D , MahmoudSH. Therapeutic drug monitoring of levetiracetam in select populations. J. Pharm. Pharm. Sci.21(1s), 149s–176s (2018).
   PubMedGoogle Scholar
• Zufia L , AldazA, IbanezNet al. LC method for therapeutic drug monitoring of levetiracetam: evaluation of the assay performance and validation of its application in the routine area. Clin. Biochem.43(4–5), 473–482 (2010).
   PubMed Web of Science ®Google Scholar
• Grim SA , RyanM, MilesMVet al. Correlation of levetiracetam concentrations between serum and saliva. Ther. Drug Monit.25(1), 61–66 (2003).
   PubMed Web of Science ®Google Scholar
• Rao BM , RaviR, ShyamSundar Reddy Bet al. A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase. J. Pharm. Biomed. Anal.35(5), 1017–1026 (2004).
   PubMed Web of Science ®Google Scholar
• Juenke J , BrownPI, UrryFM, McMillinGA. Drug monitoring and toxicology: a procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV. J. Anal. Toxicol.30(1), 27–30 (2006).
   PubMed Web of Science ®Google Scholar